Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Giacobbe

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Psychiatric Services (Washington, D.C.)|October 4, 2008
Rates and patterns of treatment seeking by individuals with mood and anxiety disordersPeter Giacobbe, Roger S McIntyre, Benjamin I Goldstein, et al.
Journal of Psychiatric Research|January 29, 2021
Investigating the role of CB1 endocannabinoid transmission in the anti-fear and anxiolytic-like effects of ventromedial prefrontal cortex deep brain stimulationDarryl C Gidyk, Mustansir Diwan, Flavia Venetucci Gouveia, et al.
Bipolar Disorders|November 3, 2010
Neurosurgical treatment of bipolar depression: defining treatment resistance and identifying surgical targetsNir Lipsman, Roger S McIntyre, Peter Giacobbe, et al.
Operative Neurosurgery (Hagerstown, Md.)|August 1, 2020
Magnetic Resonance-Guided Focused Ultrasound Capsulotomy for Treatment-Resistant Psychiatric DisordersBenjamin Davidson, Clement Hamani, Yuexi Huang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 10, 2016
Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depressionLaura Schulze, Sarah Wheeler, Mary Pat McAndrews, et al.
Journal of Affective Disorders|July 12, 2014
Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind studySidney H Kennedy, Peter Giacobbe, Franca Placenza, et al.
Psychiatry Research|January 4, 2026
Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase)Omer A Syed, Sean M Nestor, Muhammad Ishrat Husain, et al.
The Lancet. Psychiatry|November 1, 2020
Neuromodulation for major depressive disorder: innovative measures to capture efficacy and outcomesJennifer S Rabin, Benjamin Davidson, Peter Giacobbe, et al.
Neurobiology of Disease|June 5, 2023
Reduction of aggressive behaviour following hypothalamic deep brain stimulation: Involvement of 5-HTFlavia Venetucci Gouveia, Mustansir Diwan, Raquel C R Martinez, et al.
Brain Stimulation|June 17, 2020
Lack of clinical response to deep brain stimulation of the medial forebrain bundle in depressionBenjamin Davidson, Peter Giacobbe, Karim Mithani, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Psychiatric Services (Washington, D.C.)|October 4, 2008
Rates and patterns of treatment seeking by individuals with mood and anxiety disordersPeter Giacobbe, Roger S McIntyre, Benjamin I Goldstein, et al.
Journal of Psychiatric Research|January 29, 2021
Investigating the role of CB1 endocannabinoid transmission in the anti-fear and anxiolytic-like effects of ventromedial prefrontal cortex deep brain stimulationDarryl C Gidyk, Mustansir Diwan, Flavia Venetucci Gouveia, et al.
Bipolar Disorders|November 3, 2010
Neurosurgical treatment of bipolar depression: defining treatment resistance and identifying surgical targetsNir Lipsman, Roger S McIntyre, Peter Giacobbe, et al.
Operative Neurosurgery (Hagerstown, Md.)|August 1, 2020
Magnetic Resonance-Guided Focused Ultrasound Capsulotomy for Treatment-Resistant Psychiatric DisordersBenjamin Davidson, Clement Hamani, Yuexi Huang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 10, 2016
Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depressionLaura Schulze, Sarah Wheeler, Mary Pat McAndrews, et al.
Journal of Affective Disorders|July 12, 2014
Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind studySidney H Kennedy, Peter Giacobbe, Franca Placenza, et al.
Psychiatry Research|January 4, 2026
Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase)Omer A Syed, Sean M Nestor, Muhammad Ishrat Husain, et al.
The Lancet. Psychiatry|November 1, 2020
Neuromodulation for major depressive disorder: innovative measures to capture efficacy and outcomesJennifer S Rabin, Benjamin Davidson, Peter Giacobbe, et al.
Neurobiology of Disease|June 5, 2023
Reduction of aggressive behaviour following hypothalamic deep brain stimulation: Involvement of 5-HTFlavia Venetucci Gouveia, Mustansir Diwan, Raquel C R Martinez, et al.
Brain Stimulation|June 17, 2020
Lack of clinical response to deep brain stimulation of the medial forebrain bundle in depressionBenjamin Davidson, Peter Giacobbe, Karim Mithani, et al.
Pageof 18